Goldman Sachs’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $248M | Buy |
2,617,297
+1,575,889
| +151% | +$149M | 0.03% | 428 |
|
|
2025
Q1 | $66.1M | Buy |
1,041,408
+763,353
| +275% | +$48.5M | 0.01% | 901 |
|
|
2024
Q4 | $12.9M | Buy |
278,055
+245,166
| +745% | +$11.4M | ﹤0.01% | 2138 |
|
|
2024
Q3 | $946K | Sell |
32,889
-93,684
| -74% | -$2.7M | ﹤0.01% | 3784 |
|
|
2024
Q2 | $1.83M | Buy |
126,573
+33,793
| +36% | +$489K | ﹤0.01% | 3240 |
|
|
2024
Q1 | $1.49M | Buy |
92,780
+52,713
| +132% | +$848K | ﹤0.01% | 3366 |
|
|
2023
Q4 | $797K | Buy |
40,067
+14,668
| +58% | +$292K | ﹤0.01% | 3726 |
|
|
2023
Q3 | $414K | Buy |
25,399
+3,453
| +16% | +$56.3K | ﹤0.01% | 3961 |
|
|
2023
Q2 | $464K | Buy |
21,946
+1,521
| +7% | +$32.2K | ﹤0.01% | 4023 |
|
|
2023
Q1 | $410K | Buy |
20,425
+2,577
| +14% | +$51.7K | ﹤0.01% | 4181 |
|
|
2022
Q4 | $466K | Sell |
17,848
-18,512
| -51% | -$484K | ﹤0.01% | 4125 |
|
|
2022
Q3 | $372K | Buy |
36,360
+24,767
| +214% | +$253K | ﹤0.01% | 4425 |
|
|
2022
Q2 | $49K | Buy |
+11,593
| New | +$49K | ﹤0.01% | 5282 |
|